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The homeobox gene Msx-2 is expressed specifically in
sites of skin appendage formation. To explore its part
in skin morphogenesis, we produced transgenic mice
expressing Msx-2 under the control of the cytomegalo-
virus promoter. The skin of these transgenic mice
was flaky, exhibiting desquamation and shorter hairs.
Histologic analysis showed thickened epidermis with
hyperproliferation, which was restricted to the basal
layer. Hyperkeratosis was also evident. A wide zone
Vertebrate skin consists of multiple layers which interactvia growth factors to regulate morphogenetic pro-cesses. Molecular mechanisms underlying the speci-fication of cells in the developing skin are still notwell understood. During the formation of stratified
epithelia, cell proliferation is limited to the basal layer, which
contains stem cells and transient amplifying cells. These cells express
integrin (Jones et al, 1995) and keratin (K) 5 and K14 (Fuchs and
Green, 1980). The generation of the suprabasal layer is accompanied
by the loss of integrin, expression of K1, K10, and other mature
keratinocyte markers such as filaggrin and involucrin (Fuchs and
Byrne, 1994). Stratification of the skin involves complex regulation
involving calcium, the protein kinase C pathway, jun, fos, ras, and
P21 (Missero et al, 1996; Rutberg et al, 1996). Proliferation of the
basal cells was recently shown to be regulated by the sonic
hedgehog/patched pathway as de-regulation of this pathway leads
to carcinoma (Johnson et al, 1996; Dahmane et al, 1997; Oro et al,
1997). Despite such progress, much remains to be learned about
how the growth of epidermis and skin appendages is regulated.
We are interested in the molecular events underlying the temporal
and spatial control of this process. We have used skin appendages
as a model to explore the function of these regulatory molecules
(Chuong et al, 1996). Among the molecules is Msx-2, a homeo-
domain-containing protein that is expressed in a variety of sites
during organogenesis, particularly in sites where tissue interactions
take place (Davidson, 1995). In craniofacial development, a muta-
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of suprabasal cells were misaligned and coexpressed
keratins 14 and 10. There was reduced expression of
integrin b1 and DCC in the basal layer. Hair follicles
were misaligned with a shrunken matrix region. The
dermis showed increased cellularity and empty vacu-
oles. We suggest that Msx-2 is involved in the growth
control of skin and skin appendages. Key words: adhesion
molecules/integrin/keratin/skin. J Invest Dermatol 113:230–
237, 1999
tion of the human Msx-2 gene was found to correlate with
premature closure of the cranial sutures, a condition found in
individuals with Boston type craniosynostosis (Jabs et al, 1993).
This condition was mimicked in transgenic mice expressing a
mutant or normal mouse Msx-2 gene (Liu et al, 1995). Transgenic
mice with a targeted disruption of the Msx-1 gene also exhibit
abnormalities in the craniofacial bones (Satokata and Maas, 1994)
demonstrating the functional involvement of Msx genes in the
growth control of calvaria. In the limb bud, Msx-2 is expressed in
the apical ectodermal ridge and both Msx-1 and Msx-2 are
expressed in the progress zone mesoderm subjacent to the apical
ectodermal ridge (Yokouchi et al, 1991; Sumoy et al, 1995). Msx
expression is apical ectodermal ridge dependent and fibroblast
growth factor dependent and is proposed to be important for the
function of the progress zone (Ferrari et al, 1998; Muneoka and
Sassoon, 1992). In the mammary gland, Msx expression is involved
in epithelial–mesenchymal interactions that regulate gland develop-
ment and Msx-2 expression was found to be regulated by estrogen
levels (Friedmann and Daniel, 1996; Phippard et al, 1996). In vitro
studies further substantiate the role of Msx genes in growth control.
Msx-1 modulates myogenic cell differentiation/proliferation by
promoting proliferation (Wang and Sassoon, 1995). Recently, a
study was conducted to search for induced genes that can reverse
the v-Ki-ras transformed NIH 3T3 cell phenotypes. Interestingly,
a carboxy-terminal fragment of Msx-2 was isolated. Expression of
endogenous Msx-2 is also upregulated in NIH3T3 cells transfected
with v-Ki-ras (Takahashi et al, 1996). These data suggest that Msx
genes play a key part in growth control.
Msx-1 and Msx-2 are found to be expressed in developing skin
in the feather placode (Noveen et al, 1995), mouse hair follicle
epithelia (Reginelli et al, 1995), and human skin epithelia (Stelnicki
et al, 1997). Their roles in skin and skin appendage development,
however, have not been defined. In Xenopus, BMP-2 can enhance
the formation of epidermis in an Msx-1-dependent pathway (Suzuki
et al, 1997). Msx-1 knockout mice have abnormal tooth and hair
growth (Satokata and Maas, 1994). LEF-1 was shown to be involved
in the induction of epithelial appendages (Zhou et al, 1995), and
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Figure 1. Endogenous Msx-2 expression as shown in transgenic
mice with a Msx-2 reporter driving expression of LacZ. Neighboring
transverse section (A, A9) and cross-section (B, B9) of skin from transgenic
mice expressing LacZ from the full length Msx-2 promoter were stained
with hematoxylin and eosin (A, B) or for β-galactosidase (A9, B9). ep,
epidermis; dp, dermal papilla. Scale bar: 60 µm.
its molecular pathway involves Msx (Kratochwil et al, 1996). These
results strongly support the importance of the Msx pathway in skin
development.
In this study we provide further insight into the role of Msx-2
in skin development. We document abnormal skin phenotypes in
transgenic mice in which Msx-2 is overexpressed under the control
of a cytomegalovirus (CMV) promoter. These mice were produced
before and used to study the role of Msx-2 in craniofacial
development (Liu et al, 1995). Overexpression of Msx-2 in skin
in vivo causes epidermal dysplasia and abnormal hair growth. The
spatially and temporally ordered process of epidermal growth
control is disrupted. These data suggest that Msx-2 is intimately
related to skin morphogenesis, and is an important element in the
pathways that modulate the timing and locale of cell proliferation
and differentiation.
MATERIALS AND METHODS
Msx-2 transgene constructs and the making of transgenic mice The
construction and generation of the Msx-2 promoter-lacZ reporter mice
were described before (Liu et al, 1994). Briefly, this transgenic mouse
contains a construct placing the regulation of the lacZ gene under the
transcriptional control of the 5.2 kb Msx-2 promoter. Expression from this
construct is consistent with the normal expression pattern of Msx-2 in skull
and limb (Liu et al, 1994); however, the skin expression has not been
examined and is shown here.
Transgenic mice with constitutively active Msx-2 expression were
reported before and phenotypes in calvaria fusion discussed (Liu et al,
1995). Skin phenotypes are reported in this study. The plasmid was
constructed by taking a fragment of the immediate early promoter of the
human CMV from pRc/CMV (Invitrogen, Carlsbad, CA) as a SalI/
HindIII fragment and ligating it to compatible sites on pBluescript SKII
(Liu et al, 1995; Stratagene, La Jolla, CA). A 2.1 kb BamHI/PstI fragment
from pKSV10 (Pharmacia, Milwaukee, WI) was then inserted into the
BamHI site to supply a polyadenylation signal and an exogenous intron. A
1.0 kb fragment of the mouse Msx-2 cDNA was inserted into the HindIII/
EcoRI sites of this expression plasmid. The 3.7 kb transgene fragment was
freed from vector sequences by digesting with NruI and BamHI, and was
gel purified and microinjected into mouse zygotes derived from B6CBA
F1 donors.
Transgenic mice were generated and analyzed as described (Hogan et al,
1986). Briefly, 4 wk old B6CBA F1 female mice were superovulated and
mated with adult B6CBA F1 males. Prior to microinjection, isolated
fertilized oocytes were cultured in M16 medium at 37°C in a humidified
incubator supplemented with 5% CO2. Approximately 2 pl of linearized
DNA (1 µg per ml) were microinjected into the male pronucleus of each
oocyte. Surviving oocytes were transferred to the oviducts of 8 wk old
pseudopregnant CD1 females. At 2 wk of age, live born animals were
analyzed for the presence of the transgene by southern blot hybridization.
Three founder lines were used in this study. Mice were housed in a
pathogen-free environment in filter-top cages. To maintain pathogen-free
Figure 2. Production of transgenic mice overexpressing Msx-2. (A)
The plasmid construct of the mutated (Pro7His) Msx-2 driven by the
CMV promoter is shown. Regions representing the probes specific to the
SV40 intron are also shown. (B) Total RNA from the skin of CMV-Msx-
2 transgenic (Tg) and nontransgenic (nTg) mice were extracted, run on
an agarose gel, and blotted with a probe specific to SV40 (A). A band of
about 4 kb is seen which is the size of the construct. The bottom panel is
the control showing the expression of 18S and 28S rRNA. (C) Msx-2
mRNA in situ hybridization in control (A, B) and transgenic mice (A9,
B9). Cross-sections of skin were viewed with bright-field (A, A9) and dark-
field (B, B9) optics. Msx-2 is present in the follicles including the matrix
region in both sibling and transgenic mice. Note that the follicles in the
transgenic mice are a smaller size and irregularly shaped in comparison
with the nontransgenic controls. See Figs 4 and 5 for hematoxylin and
eosin staining. Msx-2 overexpressing mice express large amount of Msx-2
in the epidermis and low and diffuse staining in the dermal mesenchyme.
ep, epidermis; dp, dermal papilla.
conditions, cages, bedding, and food were sterilized. In addition, bedding
was changed twice a week in a laminar flow hood. Health surveillance
was performed once a month.
b-galactosidase expression analysis Mouse skin was fixed in 4%
paraformaldehyde for 30 min and was then embedded in OCT medium
(Miles, Elkhart, IN) for frozen sections. Sections were incubated overnight
at room temperature in X-Gal staining solution (2 mM MgCl2, 0.01%
sodium deoxycholate, 0.02% NP-40, 0.1% 4-chloro-5-bromo-3-indolyl β-
galactosidase (X-gal, Research Organics, Cleveland, OH), 5 mM potassium
ferricyanide, 5 mM potassium ferrocyanide in phosphate-buffered saline).
Histologic, immunologic, and in situ hybridization analyses For
immunoalkaline phosphatase staining, the tissues were fixed with Bouin’s
fixative, dehydrated through an alcohol series, and embedded in paraffin.
Sections were rehydrated before staining and blocked for 30 min at room
temperature with Zeller’s solution. The solution was then replaced with
1 3 0.05% Tris buffered saline with Tween–20 (TBST) solution containing
1:300 dilution of antibodies. After overnight incubation, sections were
washed three times in TBST and then treated with alkaline phosphate
conjugated secondary antibody diluted in TBST for 2 h. The slides were
washed in TBST and placed in alkaline phosphate buffer for 59, and
immunostaining was detected with nitroblue tetrazolium and 5-bromo-4-
chloro-3 indolyl phosphate (Promega, Madison, WI) substrates (Jiang et al,
1998). Antibodies sources: K14, Dr Fuchs (Stoler et al, 1988); K10, Dr
Yuspa (Roop et al, 1987); integrin β1 (Chemicon, Temecula, CA); DCC
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Figure 3. Abnormal skin in the Msx-2
overexpressing transgenic mice. In panel A, the
sibling is on the top and the transgenic mouse is on
the bottom. (C, E, G) Sibling. (B, D, F, H)
Transgenic mice. Postnatal day 5. (A) Mice from
the same litter. In transgenic mice, the occipital,
posterior body, and flank regions are usually affected
most. (B) Anterior body of the transgenic mouse.
It shows scaliness and desquamation in the skin,
particularly in the occipital region. (C, D) Flank
region near the abdomen. The skins are flaky and
peeling off in the transgenic mice. (E, F) Posterior
dorsal skin over the trunk. Note the thickened and
scaly appearance in the transgenic mice. Hair growth
is inhibited in this region. (G, H) Tail. Transgenic
mice show severe hyperkeratotic changes, scaliness,
and shorter hair. Scale bars: B, G, H, 1 mm; C–F,
500 µm.
Figure 4. Histologic sections of skin from
normal and transgenic mice. Paraffin sections of
postnatal day 5 sibling (A, B) and transgenic (A9,
B9) mouse tails shown in longitudinal sections (A,
A9) and cross-sections (B, B9). Hematoxylin and
eosin staining. Note the thickened epidermis and
some irregular epidermal invaginations with
embedded hair follicles. There are shrunken hair
matrixes (arrowheads), although the follicle became
bigger distally. There are also increased empty hair
follicles (arrows). In the dermis, there are empty
vacuoles (*). Scale bars: A, 100 µm; B, 200 µm.
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Figure 5. Epidermal dysplasia and abnormal
hair follicles in Msx-2 transgenic mice. (A, A9)
Epidermis. The P5 sibling epidermis show a well
organized basal layer with suprabasal layer and
stratum corneum laid in order. Transgenic mice
showed a thickened suprabasal layer with increased
cellularity that is misaligned. There is also increased
cellularity in the upper dermis. There are no
inflammatory cells. (B, B9) Hair follicles, cross-
sections. Note the shrunken matrix regions resulting
in irregular follicle contour in the transgenic mouse.
(C, C9) Hair follicles, longitudinal sections. Note
the bulb regions of the transgenic mice are poorly
developed and there are fewer matrix epithelial cells
and thinner outer root sheath. Scale bar: 100 µm.
(‘deleted in colorectal cancer’) (Chuong et al, 1994); and neural cell
adhesion molecule (NCAM) (Chuong et al, 1982).
For in situ hybridization, skin on the dorsal side of the body was fixed
in freshly prepared 4% paraformaldehyde, dehydrated, embedded in paraffin,
and sectioned. Sections (7 mm thick) were mounted on 3-triethoxysilylpro-
pylamine (Sigma, St Louis, MO) treated slides. Sections were deparaffinized,
hydrated, treated with 10 mg per ml proteinase K, fixed, and acetylated.
The anti-sense Msx-2 RNA probe was transcribed off pCRIIcMsx-2 by
using SP6 RNA polymerase (Pharmacia) and the sense probe was transcribed
using T7 RNA polymerase in the presence of 35S uracil triphosphate
(Amersham, Arlington Heights, IL). Probes were not hydrolyzed. Hybrid-
ization was carried out overnight at 50°C at a probe concentration of
50 000 cpm per ml. Slides were washed twice in 4 3 sodium citrate/
chloride buffer at 50°C and once at 65°C in 50% formamide, 2 3 sodium
citrate/chloride buffer, 10 mM dithiothreitol. Unbound probes were then
degraded by treating slides with 20 mg per ml RNase A at 37°C for
30 min. A final stringent wash was done at 50°C in 0.1 3 sodium citrate/
chloride buffer. After dehydration, slides were coated with photographic
emulsion (Amersham) and were exposed for 14 d at 40°C. Slides were
developed using Kodak D-19 developer and fixer.
Bromodeoxyuridine (BrdU) labeling BrdU (50 µg per kg body
weight) was injected to the mouse 1 h prior to being killed. The mouse
skin was then fixed with 4% paraformaldehyde, dehydrated, and embedded
in paraffin. After sectioning, the slides were de-waxed, the cellular DNA
was denatured in 1.5 M HCl for 30 min and neutralized with phosphate-
buffered saline for 1 h. Proliferating cells were stained with monoclonal
anti-BrdU antibody following the recommended protocol (Boehringer
Mannheim, Indianapolis, IN).
RESULTS
Endogenous Msx-2 expression pattern The normal expression
pattern of Msx-2 has been shown to be in the matrix epithelial
cells of hair follicles and the nail bed by in situ hybridization
(Reginelli et al, 1995). We have used in situ hybridization and a
Msx-2 promoter driven reporter to examine endogenous Msx-2
expression. The promoter-reporter method is used in conjunction
with in situ hybridization because it is more sensitive and allows
future analysis of the regulation of Msx-2 expression. Transgenic
mice with β-galactosidase driven from the full 5.2 kb length Msx-
2 promoter were produced (Liu et al, 1994). Neighboring transverse
and cross-sections of the skin of these mice at day 7 were stained
for hematoxylin and eosin (Fig 1A, B) and for β-galactosidase
(Fig 1A9, B9). The β-galactosidase expression pattern shows that
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Figure 6. K10, K14, and BrdU labeling in Msx-
2 transgenic mice. Paraffin sections of sibling (A–
C) and transgenic (A9–C9) mice were stained with
antibodies to K10 (A, A9) and K14 (B, B9). In the
normal mice, K10 is in the suprabasal and K14 in
the basal layer and at most one more layer above
the basal layer. In the transgenic mice, a major
portion of the thickened epidermis is positive for
both K10 and K14. (C, C9) BrdU labeling. Note
BrdU labeling in the skin of transgenic mice is still
limited to the basal layer, but the number is higher.
Scale bar: 100 µm.
Figure 7. Expression of integrin b1, DCC, and NCAM in Msx-2
transgenic mice. Frozen sections of sibling (A, C, E) and transgenic (B,
D, F) mice were stained with antibodies to DCC (A, B), integrin β1 (C,
D), and NCAM (E, F). Note DCC and integrin β1 are expressed in the
basal layer of the normal epidermis, but becomes very weak in the epidermis
of the transgenic mice. NCAM is in the superficial dermis of the control
mice. In the CMV-Msx-2 mice, the regions of superficial dermis are
expanded and the zone expressing NCAM also becomes wider. Scale
bar: 100 µm.
Msx-2 is expressed in the hair follicles including the matrix. In situ
hybridization showed a similar pattern (Fig 3A, A9).
Abnormal skin in Msx-2 overexpressing transgenic mice To
produce transgenic mice overexpressing Msx-2, Msx-2 was placed
under the control of the CMV immediate early gene promoter
(Fig 2A). Transgenic expression was verified using northern blot
hybridization with probes to the SV40 sequences. A 3.1 kb band
representing transgene expression can be detected in RNA extracted
from the skin of transgenic but not from nontransgenic mice
(Fig 2B). The overexpression of Msx-2 was further verified by in
situ hybridization (Fig 2C). The distribution in control embryos
was similar to the control (Reginelli et al, 1995). In the transgenic
mice, Msx-2 was highly expressed in the epidermis. Msx-2 was
also in the hair follicles and the distorted pattern was due to the
misshapen and shrunken hair follicles (see below, Figs 4 and 5). A
lower and diffuse presence of Msx-2 was also seen in the dermal
mesenchyme.
Three independent mouse lines were generated and all showed
similar skin phenotypes. Newborn transgenic mice showed marked
skin abnormalities. The major gross changes were thickened skin
with hyperkeratosis, desquamation and flakiness (Fig 3). In some
regions fewer hairs were observed. This may be a failure of the
hair shaft to emerge out of the skin due to inappropriate hair
follicle angles (see below). The severity of changes was regional.
The most severe region was the tail, then the dorsal posterior skin,
flank region, occipital region, and then other trunk regions. All
regions with these abnormal changes gradually decreased in size
over time, becoming patches of abnormality. These alterations were
observed in both male and female transgenic mice. The phenotypes
were more clear in the first 2 wk after birth. In transgenic mice
older than 1 mo, the skin phenotypes were no longer apparent.
Histologic sections showed abnormal histology in the epidermis,
dermis, and hair follicles (Figs 4 and 5). In the epidermis, the
stratum corneum was thicker and accompanied by hyperkeratotic
changes; therefore, more hair follicles were embedded in the
epidermis. Hair follicles were misaligned. The follicles spread
through different depths of the dermal layer. The angles were
irregular and some hair shafts appeared to fail to find a way out.
The number of empty hair canals was higher in transgenic mice
than in control siblings. In the dermis, there were vacuolated tissues
that replaced normal connective tissue (Figs 4 and 5).
At a high power view, there was increased cellularity and
dysplastic changes in the epidermis of the transgenic mice. Cells in
the stratum basale still showed the palisade arrangement, but the
cell density was higher than in the sibling. In the suprabasal layers,
the orderly and parallel transition of cells from the stratum spinosum
to the corneum in the normal mice was disrupted. Instead, many
cells were randomly distributed in the suprabasal layers of transgenic
mouse skin (Fig 5A, A9). In the superficial dermis, the regions
immediately adjacent to the epidermis showed hypercellularity in
the transgenic mice (Fig 5A, A9). Overall, the cell nuclei in the
transgenic mice were dense and tightly packed, unlike the normal
nuclei that were usually plump with distinct nucleoli. No inflam-
matory cells were observed.
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In the hair of nontransgenic mice, Msx-2 was expressed in the
matrix epithelium surrounding the dermal papilla. Increased doses
of Msx-2 produced cells with condensed and elongated nuclei,
rather than the round and plump morphology found in the sibling
(Fig 5B–C9). The matrix region was narrower than the control,
and keratinization started earlier (more proximal) than in the
control, making the matrix regions of the transgenic mice shorter
than the sibling. Overall, there were fewer matrix epithelial cells
in the transgenic mice. Regions corresponding to the inner root
sheath were also poorly developed. Interestingly, more distal to
this region, the cortex and medulla regions appeared close to
normal. Therefore, there was a poorly developed bulb region and
hair follicle (Fig 5C, C9). At the proximal level of the follicle, the
concentric rings of the outer root sheath, inner root sheath, and
matrix cells in the normal hair (Fig 5B, B9) were lost and replaced
by irregularly arranged cells. More distal, however, the cortex and
medulla appeared to be more normal.
Disrupted growth control in the skin of Msx-2 transgenic
mice To test the keratin type expressed by epidermis of the
CMV-Msx-2 transgenic mice, we examined the expression of K10
and K14. K10 is normally expressed in the suprabasal keratinocytes
(Fuchs and Green, 1980) (Fig 6A). In Msx-2 overexpressing
transgenic mice, the thickened layer of suprabasal keratinocytes
expressed K10, but the basal layer remained K10 negative (Fig 6A9).
In control mice, K14 was expressed in the basal layer and in part
of the outer root sheath of hair follicles (Fig 6B). In Msx-2
transgenic mice, K14 expression extended beyond the basal layer
and was positive in most of the suprabasal keratinocytes (Fig 6B9).
The most superficial layer, representing more differentiated ker-
atinocytes, however, remained negative for K14. Thus the majority
of the dysplastic keratinocyte population that constitutes the
thickened epithelium displayed an ambiguous property by
expressing both basal and suprabasal keratins.
We then tested for cell proliferation. BrdU was used to label
Msx-2 transgenic and control mice for 1 h before the animals were
killed. In the basal layer, BrdU-labeled cells were mildly increased.
There were no labeled nuclei in the suprabasal layer, however, and
all proliferating cells were still limited to the basal layer (Fig 6C,
C9), suggesting that overexpression of Msx-2 in the epidermis did
not cause an overwhelming proliferation of the epidermal cells.
The results suggest that Msx-2 may be involved in regulating the
timing of proliferation and differentiation, namely growth control.
Ectopic expression of Msx-2 caused loss of regulated control,
probably by accelerating the whole process.
To test the effect of Msx expression on cell interactions, we
examined the expression of cell surface molecules implicated in
growth control. We showed recently that DCC is predominantly
expressed in the basal layer of stratified epithelium (Chuong et al,
1994; Combates et al, 1997) (Fig 7(A). In Msx-2 transgenic mice,
DCC expression became weak and diffuse in both the basal and
suprabasal layers, whereas some staining remained in the outer root
sheath (Fig 7B). Normally, integrin β1 is expressed in the basal
layer and disappears in the suprabasal layer when cells start to
differentiate (Jones et al, 1995) (Fig 7C). In Msx-2 transgenic mice,
integrin β1 was diminished in the basal layer (Fig 7D). Integrin
β1 did not disappear in all the tissues in transgenic mice as some
integrin β1 staining remained in the outer root sheath of hair
follicles. This suggests that the basal cells in CMV-Msx-2 mice
have altered cell surface properties and cell interactions may not
function properly because some signaling pathways may have
been altered.
In normal mice, NCAM was also positive in the superficial
dermis, which is composed of dense dermal cells immediately
beneath the epidermis and adjacent to the hair follicles (Fig 7E).
In Msx-2 transgenic mice, this zone of superficial dermis was
thickened and remained NCAM positive (Fig 7F). Thus there was
increased NCAM expression in the dermis, which may lead
to abnormal morphogenetic activity and the observed abnormal
architecture of connective tissues, including the many vacuoles.
DISCUSSION
During development, through cell and tissue interactions, epithelial
cells differentiate into multiple types of keratinocytes that form
skin and skin appendages. It is generally agreed that epithelial stem
cells give rise to transiently amplifying cells in the epidermal basal
layer and the hair follicle matrix region, from which differentiated
keratinocytes are generated in a precise temporal and spatial
sequence (Cotsarelis et al, 1990; Carroll et al, 1995). This progression
from proliferation to differentiation must require cell interactions
and molecular controls. The mechanisms of this process remain
mostly unknown.
The expression patterns of Msx-2 in the feather placode (Noveen
et al, 1995) and hair matrix (Reginelli et al, 1995) suggest that
Msx-2 is transiently expressed in skin appendage keratinocyte
precursors at the time when cells proliferate and acquire competence
(the ability to differentiate when receiving appropriate signals). The
acquisition of competence is a transient state that requires intricate
regulation to keep growth and differentiation in balance. Here we
examined the role of Msx-2 in skin and skin appendage development
using Msx-2 overexpressing transgenic mice. We reported the
phenotypes of hyperkeratosis, desquamation, and flakiness in the
skin. The observed phenotypes were regional specific, being more
severe in the neck, flank, and tail regions. The phenotypes were
also temporal dependent, being more severe in the first 2 wk after
birth and gradually recovering. The skin of transgenic mice older
than 1 mo appear to be normal. Our preliminary data, however,
showed that re-initiation of the hair cycle by wax stripping can
cause a renewed difference between control and transgenic mice,
which again becomes less obvious 2 wk after the stripping (not
shown). The involvement of Msx in the hair cycle is itself
interesting, and is currently undergoing investigation. The alleviated
phenotypes during aging could be due to transient action of Msx-
2 in a developmental stage specific manner, the compensation by
other Msx-related pathways, or the silencing of CMV promoters
(Loser et al, 1998).
Overexpression of Msx-2 disrupts the molecular environment
and the balance of growth control in the skin In normal
skin epidermis, cells proliferate only in the basal layer. With
appropriate signals, cells begin to differentiate and move upward
to form the suprabasal layer and ultimately to cornify. In addition to
the distinct cytoarchitecture, characteristic differentiation molecules
mark different layers. K5 and K14 are basal keratins expressed only
in the basal layer, although the proteins can still be detected beyond
the basal layer. K1 and K10 are suprabasal keratins (Fuchs and
Byrne, 1994). When Msx-2 was constitutively expressed, the skin
became hyperkeratotic and flaky. Histologic examination showed
thickened epidermis with disrupted cytoarchitecture. The palisade
arrangement of the basal layer was lost, and the parallel stack of
thick to thin suprabasal cells was replaced by randomly oriented
polygonal cells, suggesting a dysplastic change. We used markers
for cell proliferation and cell differentiation to examine the effects
of Msx-2 overexpression. BrdU labeling showed that cell prolifera-
tion in the Msx-2 overexpressing mice was still limited to the basal
layer, although a higher frequency of BrdU labeling was observed.
In the suprabasal layer, cells started to express K10 and filaggrin
earlier than controls, leading to a thickened layer of keratinocytes
with an ambiguous identity characterized by coexpression of both
K10 and K14 keratins, markers of undifferentiated and differentiated
keratinocytes, respectively. This suggests that the ectopic expression
of Msx-2 in stratified epidermis disrupted the balanced proliferation/
maturation process of basal cells. Suprabasal keratinocytes differenti-
ate precociously in conjunction with increased cell proliferation in
the basal layer.
In the hair, Msx-2 is normally expressed in the matrix (Reginelli
et al, 1995). This is the region of active cell proliferation that
produces the majority of cells for the hair filament. Mice over-
expressing Msx-2 had a shrunken matrix region with a reduced
number of hair keratinocyte precursors, whereas the morphology
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and diameter of the hair shafts, once formed, appeared to be
normal. Again misexpression of Msx-2 may alter the flux of cells
between proliferation and differentiation states, thus leading to the
abnormal hair follicle formation.
What events lie downstream to Msx-2? Cell adhesion molecules
such as integrin have been shown to play critical roles in regulating
the differentiation of keratinocyte precursors (Bagutti et al, 1996).
Integrin β1 is expressed in the basal layer and becomes lost when
basal cells start to differentiate (Jones and Watt, 1993). Perturbation
of integrin–fibronectin interactions using anti-fibronectin antibodies
induces precocious epidermal differentiation (Adams and Watt,
1989). Here we observed a suppression of integrin β1 in the basal
layer (Fig 7). It is possible that the precocious effect of overexpress-
ing Msx-2 in the epidermis may be mediated through suppressed
activity of an integrin–extracellular matrix pathway. Another altered
adhesion molecule is DCC, a calcium-independent adhesion molec-
ule and a putative tumor suppressor in colon carcinoma (Fearon
et al, 1990). DCC is highly expressed in the basal layer of epidermis,
hair bulge epithelia, and the crypt region of intestinal microvilli
(Chuong et al, 1994; Combates et al, 1997), suggesting a role in
regulating cell proliferation. In Msx-2 overexpressing mice, DCC
in the basal layer is suppressed (Fig 7). The suppression of DCC
in the transgenic mice again suggests that the basal cells do not
have normal properties and loss of DCC mediated interactions may
account for de-regulation of growth control. Change of adhesion
molecular profiles in the basal cells of Msx-2 overexpressing
transgenic mice may lead them to respond differently to environ-
mental cues. Further studies are required to elucidate the mechanism
by which Msx-2 can influence epidermal stratification.
Msx-2 may be involved in regulating epidermis
thickness The function of Msx-1 and Msx-2 in development
has been studied in osteoblast differentiation (Hoffmann et al, 1994),
limb bud development (Coelho et al, 1993), muscle differentiation
(Wang and Sassoon, 1995), and tooth development (Chen et al,
1996). Whereas Msx genes are expressed in sites of epithelial–
mesenchymal interactions, their expression is more sensitive to
modulation at the time of growth control. Their exact roles seem
to differ depending on the context. Overall, Msx genes appear to
act as modifiers of transcriptional activity and gene expression
(Catron et al, 1995) probably through interactions with other
molecules such as dlx (Zhang et al, 1997) or miz-1 (Wu et al,
1997). Msx-1 may also mediate the effect of BMP4 in the formation
of the epidermis (Suzuki et al, 1997).
In the formation of stratified epithelium, the epidermis can be
divided into differentiation and proliferation layers. The border
between these two layers is set by the last proliferation event and
the initiation of differentiation. We propose a hypothetical gate
regulating the flow of cells from a proliferating compartment to a
differentiated compartment. Positive and negative regulators would
act to keep an appropriate level of transiently amplifying cells
proliferating whereas allowing a certain number of cells to progress
to differentiation. When this ‘gate’ is wide open, as may occur in
Msx-2 transgenic mice, there is a rapid transit into differentiated
status. The result is precocious differentiation and accelerated
depletion of the transiently amplifying cell pool. This depletion
may induce the accelerated proliferation in the basal layer to
replenish the cells. The result is a thickened epithelium with
hyperkeratosis.
The whole picture of the regulation of epidermal thickness,
however, is likely to be much more complex involving the
interaction of many cytokines and intracellular regulators (Blessing
et al, 1994; Missero et al, 1996; Rutberg et al, 1996). Nevertheless,
this study points toward the functional involvement of Msx-2 in
mammalian skin development and, is consistent with a role for Msx-
2 in regulating the traffic between proliferation and differentiation.
Future research will focus on elucidating how the Msx-2 pathway
interacts with other pathways in regulating the growth control of
keratinocyte precursors, and how these pathways are involved in
the physiologic and pathologic conditions involving epithelial
development.
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